Physician profile
Timothy A Manzone
NPI 1235173832
$8,810.57
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $149 · 2021: $18.59 · 2022: $108 · 2023: $2,334 · 2024: $5,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,078 · Consulting Fee: $1,725 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,050 · Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,078.19 |
| Consulting Fee | $1,725.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,050.00 |
| Food and Beverage | $159.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daxor Corporation | $8,006.22 | 2022-2024 | Bva-100 |
| Amgen INC. | $451.27 | 2019-2020 | |
| Daiichi Sankyo INC. | $114.29 | 2023 | Enhertu |
| Kite Pharma, INC. | $99.00 | 2019 | |
| Advanced Accelerator Applications | $81.82 | 2019 | |
| Sirtex Medical INC | $39.38 | 2020 | |
| Siemens Medical Solutions USA, INC. | $18.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Manzone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.